Spatiotemporal modelling and mapping of cervical cancer incidence among HIV positive women in South Africa: a nationwide study.
Journal
International journal of health geographics
ISSN: 1476-072X
Titre abrégé: Int J Health Geogr
Pays: England
ID NLM: 101152198
Informations de publication
Date de publication:
29 06 2021
29 06 2021
Historique:
received:
23
02
2021
accepted:
15
06
2021
entrez:
30
6
2021
pubmed:
1
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Disparities in invasive cervical cancer (ICC) incidence exist globally, particularly in HIV positive women who are at elevated risk compared to HIV negative women. We aimed to determine the spatial, temporal, and spatiotemporal incidence of ICC and the potential risk factors among HIV positive women in South Africa. We included ICC cases in women diagnosed with HIV from the South African HIV cancer match study during 2004-2014. We used the Thembisa model, a mathematical model of the South African HIV epidemic to estimate women diagnosed with HIV per municipality, age group and calendar year. We fitted Bayesian hierarchical models, using a reparameterization of the Besag-York-Mollié to capture spatial autocorrelation, to estimate the spatiotemporal distribution of ICC incidence among women diagnosed with HIV. We also examined the association of deprivation, access to health (using the number of health facilities per municipality) and urbanicity with ICC incidence. We corrected our estimates to account for ICC case underascertainment, missing data and data errors. We included 17,821 ICC cases and demonstrated a decreasing trend in ICC incidence, from 306 to 312 in 2004 and from 160 to 191 in 2014 per 100,000 person-years across all municipalities and corrections. The spatial relative rate (RR) ranged from 0.27 to 4.43 in the model without any covariates. In the model adjusting for covariates, the most affluent municipalities had a RR of 3.18 (95% Credible Interval 1.82, 5.57) compared to the least affluent ones, and municipalities with better access to health care had a RR of 1.52 (1.03, 2.27) compared to municipalities with worse access to health. The results show an increased incidence of cervical cancer in affluent municipalities and in those with more health facilities. This is likely driven by better access to health care in more affluent areas. More efforts should be made to ensure equitable access to health services, including mitigating physical barriers, such as transportation to health centres and strengthening of screening programmes.
Sections du résumé
BACKGROUND
Disparities in invasive cervical cancer (ICC) incidence exist globally, particularly in HIV positive women who are at elevated risk compared to HIV negative women. We aimed to determine the spatial, temporal, and spatiotemporal incidence of ICC and the potential risk factors among HIV positive women in South Africa.
METHODS
We included ICC cases in women diagnosed with HIV from the South African HIV cancer match study during 2004-2014. We used the Thembisa model, a mathematical model of the South African HIV epidemic to estimate women diagnosed with HIV per municipality, age group and calendar year. We fitted Bayesian hierarchical models, using a reparameterization of the Besag-York-Mollié to capture spatial autocorrelation, to estimate the spatiotemporal distribution of ICC incidence among women diagnosed with HIV. We also examined the association of deprivation, access to health (using the number of health facilities per municipality) and urbanicity with ICC incidence. We corrected our estimates to account for ICC case underascertainment, missing data and data errors.
RESULTS
We included 17,821 ICC cases and demonstrated a decreasing trend in ICC incidence, from 306 to 312 in 2004 and from 160 to 191 in 2014 per 100,000 person-years across all municipalities and corrections. The spatial relative rate (RR) ranged from 0.27 to 4.43 in the model without any covariates. In the model adjusting for covariates, the most affluent municipalities had a RR of 3.18 (95% Credible Interval 1.82, 5.57) compared to the least affluent ones, and municipalities with better access to health care had a RR of 1.52 (1.03, 2.27) compared to municipalities with worse access to health.
CONCLUSIONS
The results show an increased incidence of cervical cancer in affluent municipalities and in those with more health facilities. This is likely driven by better access to health care in more affluent areas. More efforts should be made to ensure equitable access to health services, including mitigating physical barriers, such as transportation to health centres and strengthening of screening programmes.
Identifiants
pubmed: 34187465
doi: 10.1186/s12942-021-00283-z
pii: 10.1186/s12942-021-00283-z
pmc: PMC8244168
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Subventions
Organisme : NIAID NIH HHS
ID : U01 AI069924
Pays : United States
Organisme : Medical Research Council
ID : MR/T025352
Pays : United Kingdom
Organisme : NIH HHS
ID : U01AI069924-09
Pays : United States
Références
Health Policy Plan. 2017 Apr 01;32(3):430-436
pubmed: 27935803
Int J Cancer. 2020 Feb 1;146(3):601-609
pubmed: 31215037
Gynecol Oncol Rep. 2017 Jul 21;21:101-108
pubmed: 28819634
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):591-9
pubmed: 21266522
J Clin Oncol. 2006 Mar 20;24(9):1383-8
pubmed: 16549832
Asian Pac J Cancer Prev. ;17(11):5011-5017
pubmed: 28032732
PLoS One. 2019 Mar 11;14(3):e0213086
pubmed: 30856196
Lancet Oncol. 2019 Mar;20(3):394-407
pubmed: 30795950
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
BMC Public Health. 2015 Apr 15;15:382
pubmed: 25886513
Lancet HIV. 2018 Jan;5(1):e45-e58
pubmed: 29107561
J Natl Cancer Inst. 2011 May 4;103(9):753-62
pubmed: 21483021
Int J Cancer. 2018 Nov 1;143(9):2238-2249
pubmed: 29786136
Lancet Glob Health. 2021 Feb;9(2):e161-e169
pubmed: 33212031
Infect Agent Cancer. 2014 Mar 05;9(1):1
pubmed: 24597902
PLoS One. 2015 Aug 12;10(8):e0135602
pubmed: 26267867
Health Econ Policy Law. 2013 Jan;8(1):21-46
pubmed: 22469113
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):882-889
pubmed: 30733307
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Stat Med. 2000 Sep 15-30;19(17-18):2555-67
pubmed: 10960871
Lancet Oncol. 2009 Apr;10(4):321-2
pubmed: 19350698
J Int AIDS Soc. 2020 Jul;23(7):e25546
pubmed: 32640106
South Afr J HIV Med. 2017 Jul 27;18(1):694
pubmed: 29568630
Br J Cancer. 2010 Jul 27;103(3):416-22
pubmed: 20588274
J Natl Cancer Inst Monogr. 2001;(28):1-4
pubmed: 11158199
Spat Spatiotemporal Epidemiol. 2020 Feb;32:100319
pubmed: 32007284
Womens Health Issues. 2014 Sep-Oct;24(5):519-27
pubmed: 25128038
Eur J Cancer Prev. 2009 Sep;18(5):395-403
pubmed: 19609213
Lancet Public Health. 2019 Jan;4(1):e19-e27
pubmed: 30291040
Int J Cancer. 2017 Aug 1;141(3):488-496
pubmed: 28440019
BMC Health Serv Res. 2016 Oct 7;16(1):558
pubmed: 27717353
Lancet Oncol. 2019 Mar;20(3):319-321
pubmed: 30795952
Lancet Oncol. 2015 Aug;16(8):e414-21
pubmed: 26248849
PLoS One. 2018 Oct 24;13(10):e0205425
pubmed: 30356248
S Afr Med J. 2015 Jan 12;105(2):107-9
pubmed: 26242527
AIDS. 2015 Jul 17;29(11):1401-9
pubmed: 26091299
Infect Agent Cancer. 2010 May 12;5:8
pubmed: 20462441
Int J Cancer. 2006 Feb 15;118(4):985-90
pubmed: 16106415